POSPÍŠILOVÁ, Šárka and Andrew PETTITT. p53 dysfunction in chronic lymphocytic leukemia. In K. Stamatopoulos, P. Ghia, R. Rosenquist. New Biological Prognostic Markers in Chronic Lymphocytic Leukemia. Milano: Wolters Kluwer Helath Italy Ltd. p. 73-95. ISBN 978-88-7556-551-0. 2010.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name p53 dysfunction in chronic lymphocytic leukemia
Authors POSPÍŠILOVÁ, Šárka (203 Czech Republic, guarantor, belonging to the institution) and Andrew PETTITT (826 United Kingdom of Great Britain and Northern Ireland).
Edition Milano, New Biological Prognostic Markers in Chronic Lymphocytic Leukemia, p. 73-95, 23 pp. 2010.
Publisher Wolters Kluwer Helath Italy Ltd
Other information
Original language English
Type of outcome Chapter(s) of a specialized book
Field of Study 30200 3.2 Clinical medicine
Country of publisher Italy
Confidentiality degree is not subject to a state or trade secret
Publication form printed version "print"
RIV identification code RIV/00216224:14110/10:00059308
Organization unit Faculty of Medicine
ISBN 978-88-7556-551-0
Keywords in English lymphocytic leukemia; tumor suppressor; p53
Tags ok, rivok
Tags International impact, Reviewed
Changed by Changed by: Olga Křížová, učo 56639. Changed: 19/4/2013 19:35.
Abstract
The p53 protein plays a key role in protecting cells against malignant transformation by preventing the accumulation of genomic alterations and is probably the most extensively studied protein.
PrintDisplayed: 28/3/2024 11:45